Get the Stockscreener App
3.03
6.48%
-0.21
After Hours:
3.20
0.17
+5.61%
Protagenic Therapeutics Inc stock is traded at $3.03, with a volume of 133.56K.
It is down -6.48% in the last 24 hours and down -5.90% over the past month.
Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression, and neurodegenerative disorders by using peptide-based and brain-active therapeutics. The company's main compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders.
See More
Previous Close:
$3.24
Open:
$3.15
24h Volume:
133.56K
Relative Volume:
0.05
Market Cap:
$5.80M
Revenue:
-
Net Income/Loss:
$-5.00M
P/E Ratio:
-2.6348
EPS:
-1.15
Net Cash Flow:
$-3.85M
1W Performance:
-9.82%
1M Performance:
-5.90%
6M Performance:
-29.96%
1Y Performance:
-59.17%
1-Day Range:
$2.92
$3.20
1-Week Range:
$2.92
$3.77
52-Week Range:
$2.25
$15.26
Protagenic Therapeutics Inc Stock (PTIX) Company Profile
Name
Protagenic Therapeutics Inc
Sector
Industry
Phone
(212) 994-8200
Address
149 FIFTH AVENUE, NEW YORK
Compare PTIX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PTIX
Protagenic Therapeutics Inc
|
3.03 | 6.20M | 0 | -5.00M | -3.85M | -1.15 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Protagenic Therapeutics Inc Stock (PTIX) Latest News
How Protagenic Therapeutics Inc. Equity Warrant stock benefits from strong dollar2025 Geopolitical Influence & Stepwise Swing Trade Plans - newser.com
Why Protagenic Therapeutics Inc. is moving todayQuarterly Performance Summary & Accurate Trade Setup Notifications - newser.com
Is Protagenic Therapeutics Inc. Equity Warrant stock trading near support levels2025 Key Highlights & Free Real-Time Volume Trigger Notifications - newser.com
Can momentum traders help lift Protagenic Therapeutics Inc. Equity Warrant2025 Sector Review & Fast Moving Stock Watchlists - newser.com
Real time pattern detection on Protagenic Therapeutics Inc. stockJuly 2025 Catalysts & Daily Risk Controlled Trade Plans - newser.com
Sector ETF performance correlation with Protagenic Therapeutics Inc.2025 Retail Activity & Weekly High Momentum Picks - newser.com
Has Protagenic Therapeutics Inc. Equity Warrant found a price floorQuarterly Portfolio Review & AI Driven Price Predictions - newser.com
Will Protagenic Therapeutics Inc. stock outperform Dow Jones indexJuly 2025 Closing Moves & Reliable Volume Spike Trade Alerts - newser.com
Will Protagenic Therapeutics Inc. Equity Warrant stock reach all time highs in 2025July 2025 Summary & Daily Stock Momentum Reports - newser.com
Why Protagenic Therapeutics Inc. stock could see breakout soonLong Setup & Fast Momentum Entry Tips - newser.com
What Wall Street predicts for Protagenic Therapeutics Inc. Equity Warrant stock price2025 Major Catalysts & Growth Focused Entry Reports - newser.com
Real time social sentiment graph for Protagenic Therapeutics Inc.Gold Moves & Detailed Earnings Play Alerts - newser.com
Can Protagenic Therapeutics Inc. stock maintain operating marginsWeekly Earnings Recap & Community Verified Trade Signals - newser.com
Is Protagenic Therapeutics Inc. Equity Warrant stock attractive after correctionJuly 2025 News Drivers & AI Powered Buy and Sell Recommendations - newser.com
How to build a custom watchlist for Protagenic Therapeutics Inc. Equity WarrantTrade Risk Summary & Community Shared Stock Ideas - newser.com
Sector ETF performance correlation with Protagenic Therapeutics Inc. Equity WarrantJuly 2025 Momentum & Stepwise Entry/Exit Trade Alerts - newser.com
Detecting support and resistance levels for Protagenic Therapeutics Inc. Equity WarrantInsider Selling & Reliable Breakout Forecasts - newser.com
Is Protagenic Therapeutics Inc. Equity Warrant stock attractive for hedge funds2025 Momentum Check & Fast Moving Stock Watchlists - newser.com
Order flow analysis tools used on Protagenic Therapeutics Inc. Equity Warrant2025 Year in Review & Daily Profit Maximizing Tips - newser.com
Heatmap analysis for Protagenic Therapeutics Inc. and competitorsPortfolio Return Report & Real-Time Buy Zone Alerts - newser.com
Using data models to predict Protagenic Therapeutics Inc. stock movementJuly 2025 Outlook & High Accuracy Trade Alerts - newser.com
What MACD signals say about Protagenic Therapeutics Inc.Trade Entry Summary & Reliable Trade Execution Plans - newser.com
Real time scanner hits for Protagenic Therapeutics Inc. explainedMarket Sentiment Review & Daily Momentum Trading Reports - newser.com
Why institutional investors increase stakes in Protagenic Therapeutics Inc. (MBP0) stockEarnings Miss & Low Drawdown Momentum Trade Ideas - newser.com
Will breakout in Protagenic Therapeutics Inc. lead to full recoveryBond Market & Fast Gain Swing Trade Alerts - newser.com
Does Protagenic Therapeutics Inc. Equity Warrant qualify in momentum factor screeningInflation Watch & Free Risk Controlled Daily Trade Plans - newser.com
Will Protagenic Therapeutics Inc. Equity Warrant stock outperform tech sector in 2025CEO Change & Entry Point Strategy Guides - newser.com
Analyzing Protagenic Therapeutics Inc. Equity Warrant with risk reward ratio chartsTrend Reversal & Reliable Entry Point Alerts - newser.com
What recovery options are there for Protagenic Therapeutics Inc.Market Performance Recap & AI Driven Stock Price Forecasts - newser.com
Can Protagenic Therapeutics Inc. Equity Warrant stock deliver sustainable ROEEarnings Overview Summary & Consistent Growth Stock Picks - newser.com
Is Protagenic Therapeutics Inc. Equity Warrant reversing from oversold territoryWeekly Stock Analysis & AI Optimized Trading Strategy Guides - newser.com
Can Protagenic Therapeutics Inc. stock surprise with earnings upsideFed Meeting & Real-Time Buy Signal Alerts - newser.com
Published on: 2025-10-06 08:11:22 - newser.com
Pattern recognition hints at Protagenic Therapeutics Inc. upsideTrade Ideas & Scalable Portfolio Growth Methods - newser.com
Applying sector rotation models to Protagenic Therapeutics Inc. Equity WarrantWeekly Gains Report & Real-Time Market Sentiment Alerts - newser.com
Using Bollinger Bands to evaluate Protagenic Therapeutics Inc.July 2025 Setups & Detailed Earnings Play Strategies - newser.com
Why Protagenic Therapeutics Inc. Equity Warrant stock could be next big winnerJuly 2025 PostEarnings & Real-Time Volume Analysis - newser.com
Measuring Protagenic Therapeutics Inc.’s beta against major indices2025 Year in Review & Weekly Watchlist for Consistent Profits - newser.com
Will Protagenic Therapeutics Inc. (MBP0) stock announce special dividendWeekly Trade Summary & Low Risk Growth Stock Ideas - newser.com
How moving averages guide Protagenic Therapeutics Inc. Equity Warrant tradingJuly 2025 Pullbacks & Entry Point Strategy Guides - newser.com
Volatility clustering patterns for Protagenic Therapeutics Inc.2025 Price Momentum & Advanced Technical Signal Analysis - newser.com
Protagenic Therapeutics Inc Stock (PTIX) Financials Data
Revenue
Net Income
Cash Flow
EPS
5.15%
1.45%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):